Amvilab® and the Product “Amevit Kids” in Georgia, Public Health Institute of Georgia (PHIG) Position

Date: 25 November 2025

Status: Expert public-health opinion based on independently verifiable scientific and legal sources

1. Mandate and scope of this statement

The Public Health Institute of Georgia (PHIG) is an independent, non-commercial organization. Our mandate is to:

• Protect the health of the population;
• Promote evidence-based practice in health and nutrition;
• Support Georgian regulators and consumers in making informed choices about health products.

Part of this work is the critical assessment of food supplements and transparent communication with the public via platforms such as SheniEkimi.ge, SheniAmbebi.ge and Supplement.ge.

This statement explains why PHIG does not recommend the use of Amvilab® food supplements in Georgia at this time, with a special focus on the children’s product “Amevit Kids”, and why these products are considered a high-risk category from a public-health and regulatory perspective.

The document is not a legal ban and does not replace the authority of Georgian governmental bodies (National Food Agency, State Regulation Agency for Medical Activities, Competition and Consumer Agency, Georgian National Communications Commission, etc.). It is an independent expert risk assessment directed to:

• Consumers in Georgia;
• Healthcare professionals;
• Regulatory and oversight bodies;
• Distributors and pharmacy chains that sell Amvilab products.

2. Brand profile and regulatory context

On its official website, Amvilab presents itself as a US-based company (“Atlanta, GA”) and describes its mission as being a “trusted ally on the road to peak wellness”, offering “premium USA-made supplements” formulated to meet the wellness demands of modern life.^[1] The online catalogue lists more than 70 products across categories such as Heart & Circulation, Immune System Health, Brain & Mood Support, Men’s Health, Women’s Health, Kids Health and others.^[1–3]

The Kids Health category of the Amvilab site currently lists two products: Amevit Kids and Probiotic Kids, both explicitly described as “supplement products” and classified under Immune System Health and Kids Health.^[2,4]

At the same time, US regulatory and scientific sources make clear that dietary supplements are not regulated as medicines:

• Under the Dietary Supplement Health and Education Act (DSHEA), dietary supplements are regulated by the US Food and Drug Administration (FDA) as a category of food, not as drugs. FDA does not approve dietary supplements for safety or effectiveness before they are marketed, and firms can often introduce supplements without prior FDA notification.^[5–7,23]
• DSHEA and subsequent guidance emphasise that manufacturers are responsible for ensuring that their products are safe and that all claims are truthful and not misleading, but no pre-market demonstration of clinical efficacy is required as it is for medicines.^{[5–7,23,26]}

In the EU and Georgia, food supplements are also regulated as foods within food safety and labelling frameworks, not as medicines. Georgia’s Food/Feed Safety Code and related acts transpose much of the logic of EU food law (Regulation 178/2002, 1169/2011) into national legislation.^{[13,16,19,25]}

3. Supplements vs medicines: why this distinction matters

Because Amvilab operates both as a supplement brand and, through Amvilab LLC, as a labeler of certain OTC medicines, it is important not to confuse the two:

• For example, Colistat (docusate sodium 100 mg) appears in US drug databases as an OTC stool softener labelled by Amvilab LLC and regulated under FDA drug monographs.^[5,10,16]
• By contrast, products such as Amevit Kids, Blood Sugar Health, Magnesium & Vitamin B6, Venous Support, Prostate Expert and others are explicitly labelled as dietary supplements both on the Amvilab website and on international retail platforms.^{[1–3,6,9,12,15–18]}

Under US and Georgian law, dietary supplements:

• are not approved as medicines before marketing;^{[5–7,11,17,23,26]}
• may not claim to diagnose, treat, cure or prevent specific diseases;^{[5–7,11,19,22]}
• rely on manufacturers to ensure safety and truthful labelling, without systematic pre-market clinical trials.

PHIG’s core concern is that Amvilab’s overall brand narrative and product naming often bring food supplements very close to disease-related expectations in the eyes of consumers, without the level of evidence or regulatory scrutiny that would be required for medicines.

4. Safety and dosing: high-dose, multi-ingredient formulations

Amvilab’s portfolio includes a large number of multi-ingredient products with complex compositions:

• Blood Sugar Health is described as a “natural 20 herbs and vitamins with cinnamon” supplement for blood sugar support.^[2,6]
• Magnesium & Vitamin B6 is promoted for bone mineralisation, nerve and muscle function, brain health, daily vitality and sleep.^[9,14,15]
• Venous Support provides 450 mg diosmin + 50 mg hesperidin and is marketed for venous circulation, hemorrhoids and varicose veins.^[16]
• Prostate Expert is advertised as a “natural supplement for prostate health & urinary tract support”.^[15]

The European Food Safety Authority (EFSA) has defined Tolerable Upper Intake Levels (ULs) for many vitamins and minerals, representing the maximum daily intake from all sources (diet, fortified foods and supplements) that is unlikely to pose risk of adverse health effects.^[13,14] EFSA’s 2024 guidance stresses that:

• ULs must be considered in the context of cumulative exposure when individuals use several supplements concurrently;^[13,14]
• long-term intakes near or above ULs may produce clinically significant toxicity (e.g. neuropathy from vitamin B₆, iron overload, vitamin A toxicity, etc.).^[13,14]

Peer-reviewed research also highlights potential issues with chronic high-dose micronutrient use. For example, a 2020 review on nicotinamide (a form of vitamin B₃) summarises mechanisms by which high doses could affect metabolism, liver function and epigenetic regulation, and calls for caution in long-term high-dose use.^[9]

In this context, PHIG notes that:

• Amvilab supplements are generally taken in addition to a normal diet, and consumers frequently combine multiple supplements from Amvilab and other brands;
• Amvilab’s public materials do not systematically communicate the risk of exceeding ULs when several products are taken together;
• For children, pregnant women, older adults and patients with chronic diseases, such multi-ingredient, high-dose strategies create a non-trivial safety concern, especially without medical supervision.

PHIG does not claim that individual Amvilab products necessarily exceed ULs or national legal limits. Our concern is with the overall strategy of widespread, long-term high-dose supplementation without robust evidence of additional benefit and without clear, conservative safety messaging.

5. Marketing practices and quasi-therapeutic claims

Amvilab’s marketing often uses language that is close to disease-related claims:

• Blood Pressure Health is promoted as a supplement to maintain healthy blood pressure;^[2,3,6]
• Blood Sugar Health is advertised to support blood sugar levels with 20 herbs and vitamins plus cinnamon;^[2,6]
• Thyroid Support uses slogans like “healthy thyroid, happy life. Revitalize metabolism, energy…”;^[12]
• Venous Support is associated with hemorrhoids and varicose veins;^[16]
• Prostate Expert is targeted at prostate and urinary tract health;^[15]
• Amevit Kids is marketed as supporting children’s immunity, growth and overall development (see section 6).^[3,4,9,12]

On platforms such as Amazon and others, product descriptions sometimes add wording like “clinically shown to increase iron levels without side effects” or imply medical benefit, followed by the standard disclaimer that the statements “have not been evaluated by the FDA” and the product is “not intended to diagnose, treat, cure or prevent any disease.”^[6,15–18]

From a regulatory standpoint, this creates tension with the requirement that food-supplement advertising must:

• avoid explicit or implicit claims of disease treatment or prevention unless the product is regulated as a medicine;^{[5–7,19,22]}
• be truthful, evidence-based and non-misleading, particularly regarding health effects.

PHIG is concerned that such marketing may blur the line between food supplements and medicines in the eyes of consumers, leading them to overestimate both efficacy and safety.

6. Case study: Amevit Kids – distribution pattern and transparency

6.1. What is Amevit Kids?

On the official Amvilab website, Amevit Kids appears as a children’s multivitamin supplement in the “Kids Health” and “Immune System Health” categories.^[2,4,11,13] The product is described as:

• gummy or chewable “marmalade” bears for children;
• containing a combination of vitamins A, C, D, E, B-complex vitamins and minerals such as iodine and zinc (depending on formulation and label);^[3,11,17]
• aimed at supporting children’s general health, immunity, appetite, growth, and bone and tooth mineralisation.^{[3,5,8,10,11]}

The product has an entry in the US NIH Dietary Supplement Label Database (DSLD), where “Amevit Kids” is listed as an Amvilab brand gummy/jelly supplement with an English-language label indicating ingredients and claims such as “supports children’s general health & immunity.”^[17]

6.2. Availability in Georgia

In Georgia, Amevit Kids is widely available in major pharmacy chains and online shops:

• GPC (გიპისი) lists “Amevit kids gummies #30” as a US-made Amvilab product in its “Vitamins and minerals” food-supplement category, with detailed Georgian-language description.^[3,15]
• Pharmadepot sells “Amevit kids gummies #30” in its food-supplement section, describing it as a children’s vitamin and mineral complex in chewable marmalade form.^[1,6]
• Aversi’s online shop lists “Amevit kids marmelad #30” in the “Vitamins” group (non-prescription), again as a children’s multivitamin product.^[10]
• Local online retailers such as Veli.store also offer “Amvilab Amevit Kids, 30 pieces”, emphasising benefits for metabolism, physical and intellectual development, appetite and bone and tooth mineralisation.^[5,8]

On Supplement.ge, which is operated by PHIG under the “Safe Supplement Georgia” programme, Amevit Kids appears within the Amvilab brand cluster and is included in the overall assessment of the brand’s products.^[8,9] PHIG has also published a detailed article on SheniEkimi.ge (“‘Amevit Kids’ – why we cannot recommend this vitamin”), explaining why the product is classified as “Not Recommended” based on SSG’s 7-step evaluation (lack of publicly verifiable GMP/CoA, questionable marketing claims, added sugar, incomplete coverage of recommended intakes for key nutrients, etc.).^[9,18]

6.3. Availability in the USA and other countries

Earlier PHIG investigations (as reflected in the SheniEkimi.ge article of 1 September 2025) noted that, at that time, Amevit Kids appeared to be primarily visible in Georgian pharmacies and was not easily found on Amvilab’s then-public US website or via major international online stores, which raised questions about distribution and transparency.^[18]

Updated research conducted in November 2025, however, shows that:

• Amevit Kids now clearly appears on the official Amvilab product pages in the “Kids Health” category, labelled as a supplement.^[2,4,11]
• The NIH DSLD lists “Amevit Kids” as an Amvilab brand gummy supplement, confirming its presence in the US dietary supplement labelling system.^[17]
• Amevit Kids is sold via US-based and global online platforms such as Amazon, where it is advertised as “Amevit Kids Gummy Multivitamin – Complete Daily Vitamins for Children – with Essential Nutrients for Growth & Immunity.”^[6,12]

At the same time, PHIG was not able to identify Amevit Kids being widely stocked by major US brick-and-mortar pharmacy chains in the way it is stocked by major Georgian chains (GPC, Pharmadepot, Aversi, etc.). Outside Georgia, its availability appears to be primarily through:

• Amvilab’s own online shop;^{[1–4,11,13]}
• US/global online marketplaces (Amazon and similar);^[6,12]
• regional e-commerce platforms serving Georgia and neighbouring markets.^[5,8,15,16]

PHIG has found no clear public explanation from Amvilab or regulators as to why Amevit Kids has such a strong offline presence in Georgian pharmacies, while its distribution in most other markets appears to be primarily online. The company has not, to our knowledge, published:

• detailed regulatory dossiers specific to Amevit Kids (e.g. certificates of registration in Georgia, EU markets or other jurisdictions);
• public GMP documentation and batch-specific Certificates of Analysis (CoAs) for Amevit Kids accessible to consumers in Georgia;
• clarification of when Amevit Kids was added to the official website and DSLD relative to its long-standing prominence in Georgian pharmacies.

In PHIG’s view, this asymmetric distribution pattern – strong offline promotion in Georgia, primarily online availability elsewhere, and limited transparency about regulatory status – reinforces the decision to classify Amevit Kids as “Not Recommended” until much stronger documentation is provided.

6.4. PHIG’s SSG evaluation of Amevit Kids

Under the Safe Supplement Georgia (SSG) framework operated by PHIG, each product is assessed against a 7-step checklist (company identification, registration, GMP, CoA, labelling/traceability, safety and advertising claims).^[9,13,16,19] According to Supplement.ge and the detailed SheniEkimi.ge article on Amevit Kids:^[8,9,18]

• Amevit Kids did not pass one or more critical SSG steps (including absence of publicly verifiable GMP and CoA documentation for Georgian consumers);
• marketing claims were found to be absolute and potentially misleading relative to the actual nutrient levels and coverage of daily requirements (e.g. iodine, vitamin D, zinc);
• the product contains added sugar, which is problematic in the context of global recommendations to reduce free sugar intake in children.

As a result, Amevit Kids is currently classified on Supplement.ge as “❌ Not Recommended ❌” for use in children in Georgia.^[8,9]

7. PHIG’s official position on Amvilab and Amevit Kids in Georgia

7.1. Non-recommendation

Based on the evidence reviewed, PHIG adopts the following position as of 25 November 2025:

PHIG does not recommend the use of Amvilab® food supplements, including Amevit Kids®, in Georgia for:

• the general adult population;
• pregnant and breastfeeding women;
• children and adolescents;
• patients with chronic diseases or compromised immunity.

This non-recommendation rests on:

• The absence of robust, transparent, product-specific clinical trials showing clear benefits of Amvilab’s multi-ingredient supplements (including Amevit Kids) on hard clinical outcomes, beyond what could be achieved with standard dietary advice and appropriately targeted single-nutrient supplementation.^{[7–9,13–15]}
• The potential safety concerns related to long-term, high-dose multi-component supplementation in a setting where EFSA and other authorities emphasise respecting ULs and where some high-dose strategies may be harmful.^{[7,9,13–15]}
• The use of product names and marketing language closely tied to serious health conditions (blood pressure, blood sugar, thyroid disorders, venous insufficiency, prostate disease, childhood immunity and development), despite the products being legally food supplements that have not undergone medicine-level evaluation.^{[2,3,6,9,12,15–18]}
• The specific case of Amevit Kids, where:
  • offline distribution is particularly concentrated in Georgian pharmacies;
  • regulatory and quality documentation is not transparently available to Georgian consumers;
  • PHIG’s SSG system has classified the product as “Not Recommended” based on multiple shortcomings in documentation and marketing.^[8,9,18]
• Georgian and EU-aligned legal requirements that food-supplement advertising must be truthful, non-misleading and clearly separated from medicinal claims – requirements which, in PHIG’s view, are not fully respected for many Amvilab products currently promoted in Georgia.^{[5–7,19,22]}

7.2. Guidance for clinicians and consumers

PHIG recommends that healthcare professionals in Georgia:

• Refrain from routinely prescribing or recommending Amvilab products, including Amevit Kids, for prevention or treatment of disease where evidence-based alternatives exist (balanced diet, specific supplements in documented deficiency, established pharmacotherapy).
• Explain clearly to parents that Amevit Kids is a food supplement, not a medicine, and that PHIG currently classifies it as “Not Recommended” due to documentation and marketing concerns.
• Report any suspected adverse events related to Amvilab products to national pharmacovigilance and food-safety authorities.

For consumers, PHIG strongly advises that:

• decisions about children’s vitamins and supplements, especially for chronic conditions, should be taken in consultation with a qualified physician;
• social-media advertising and “premium supplement” branding (including Amvilab and Amevit Kids) should not replace proper medical assessment;
• independent information and analysis are available in Georgian via SheniEkimi.ge, SheniAmbebi.ge and Supplement.ge.

8. Recommendations to Georgian regulators

8.1. National Food Agency and health regulators

• Review the registration and labelling status of Amvilab products, particularly Amevit Kids, on the Georgian market (classification as food supplement; existence and adequacy of Free Sale Certificates, GMP and CoA documentation).
• Request full technical and safety dossiers for Amvilab products promoted for sensitive populations (children, pregnant women, chronic disease patients).
• Consider targeted laboratory testing of Amevit Kids and other Amvilab products sold in Georgia (composition, label compliance, contaminants).

8.2. Competition and Consumer Agency

• Assess whether Amvilab-related advertising claims (“clinically shown”, “healthy thyroid”, “for hemorrhoids and varicose veins”, etc.) comply with the Law of Georgia on Advertising and consumer-protection principles.^[19,22]
• Issue guidance or take enforcement measures if advertising is found to be misleading or insufficiently substantiated, especially for products directed at children.

8.3. Georgian National Communications Commission (GNCC)

• Monitor TV and online content for potential surreptitious advertising of Amvilab and Amevit Kids within health-themed programmes, talk shows and influencer content, in line with existing standards.^[20,21]
• Ensure that all Amvilab-related content with a commercial interest is clearly identified as advertising or sponsorship and not presented as neutral editorial or medical advice.

9. Legal robustness of PHIG’s position

In formulating this position, PHIG relies on:

• Amvilab’s own website, product categories and marketing descriptions, including specific pages for Amevit Kids;^{[1–4,11,13]}
• US regulatory and informational sources (FDA, NIH ODS, DSLD, independent reviews) describing how dietary supplements are regulated as foods and not as medicines, with no pre-market efficacy requirement;^{[5–7,11,17,23,26]}
• EFSA guidance and peer-reviewed scientific literature on ULs and potential adverse effects of long-term high-dose micronutrient use;^{[7,9,13–15]}
• Georgian and international legal resources on food safety and advertising, including the Law of Georgia on Advertising and analyses of advertising of medicines and biologically active additives;^{[19,21,22,25]}
• Publicly accessible retail listings from Georgian pharmacies and online stores demonstrating the strong offline presence of Amevit Kids in Georgia;^{[1,3,5,6,8,10,15,16,20,21]}
• PHIG’s own platforms (Supplement.ge and SheniEkimi.ge), where the “Not Recommended” status of Amvilab products, including Amevit Kids, is transparently documented.^[8,9,18]

PHIG does not allege that Amvilab products are per se illegal on the Georgian market or that they systematically exceed compositional limits. Based on the precautionary principle and the current weight of evidence, PHIG concludes that:

Amvilab’s strategy of high-dose, multi-ingredient supplementation, its frequent use of disease-adjacent marketing language, and the specific distribution and documentation issues around Amevit Kids together justify a clear precautionary message: at this time, Amvilab products – including Amevit Kids – are not recommended for routine use in Georgia, unless and until independently verified, high-quality evidence of benefit, safety and full regulatory compliance is made publicly available.

This statement is issued in good faith as an expert opinion on a matter of public health, based on sources that can be independently verified.

Sources

1. Amvilab. We’re AMVILAB – Your Trusted Ally on The Road to Peak Wellness [Internet]. Atlanta (GA): Amvilab; c2025 [cited 2025 Nov 25]. Available from: https://amvilab.com/
2. Amvilab. Products – Shop Premium USA-Made Health Supplements [Internet]. Atlanta (GA): Amvilab; c2025 [cited 2025 Nov 25]. Available from: https://amvilab.com/products/
3. Amvilab. Amevit Kids – Supplement Product [Internet]. Atlanta (GA): Amvilab; c2025 [cited 2025 Nov 25]. Available from: https://amvilab.com/product/amevit-kids/
4. Amvilab. Kids Health – Amevit Kids & Probiotic Kids [Internet]. Atlanta (GA): Amvilab; c2025 [cited 2025 Nov 25]. Available from: https://amvilab.com/product-category/kids-health/
5. US Food and Drug Administration. Dietary Supplements [Internet]. Silver Spring (MD): FDA; 2024 Oct 1 [cited 2025 Nov 25]. Available from: https://www.fda.gov/food/dietary-supplements
6. US Food and Drug Administration. Questions and Answers on Dietary Supplements [Internet]. Silver Spring (MD): FDA; 2024 Feb 21 [cited 2025 Nov 25]. Available from: https://www.fda.gov/food/…/questions-and-answers-dietary-supplements
7. Pew Charitable Trusts. Dietary Supplements: What Are They and How Are They Regulated? [Internet]. 2017 Oct [cited 2025 Nov 25]. Available from: https://www.pew.org/…/hcp_dietary_supplements_what_are_they_and_how_are_they_regulated_final.pdf
8. Supplement.ge. Amvilab – ბრენდი / Amvilab – Brand page [Internet]. Tbilisi (GE): Safe Supplement Georgia; 2025 [cited 2025 Nov 25]. Available from: https://supplement.ge/brand/amvilab/
9. Supplement.ge. პანზატი 30 კაფსულა ამვილაბი – Panazti 30 capsules Amvilab ❌ Not Recommended ❌ [Internet]. Tbilisi (GE): Safe Supplement Georgia; 2025 [cited 2025 Nov 25]. Available from: https://supplement.ge/product/პანზატი-30-კაფსულა-ამვილაბი
10. Drugs.com. Colistat – docusate sodium 100 mg tablet, film coated – Amvilab LLC [Internet]. 2025 Jul 7 [cited 2025 Nov 25]. Available from: https://www.drugs.com/otc/394863/colistat.html
11. US Food and Drug Administration. Information for Consumers on Using Dietary Supplements [Internet]. Silver Spring (MD): FDA; 2022 Oct 21 [cited 2025 Nov 25]. Available from: https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplements
12. Amazon. Amevit Kids Gummy Multivitamin – Complete Daily Vitamins for Children [Internet]. 2024 [cited 2025 Nov 25]. Available from: https://www.amazon.com/AMVILAB-Amevit-Kids-Gummy-Multivitamin/dp/B0FPMMK48C
13. European Food Safety Authority. Tolerable upper intake levels for vitamins and minerals [Internet]. Parma (IT): EFSA; 2006 [cited 2025 Nov 25]. Available from: https://www.efsa.europa.eu/…/ndatolerableuil.pdf
14. EFSA NDA Panel. Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals. EFSA J [Internet]. 2024;22(11):e9052 [cited 2025 Nov 25]. Available from: https://doi.org/10.2903/j.efsa.2024.9052
15. Hwang ES, Song SB. Possible adverse effects of high-dose nicotinamide: mechanisms and safety assessment. Biomolecules. 2020;10(5):687. Available from: https://www.mdpi.com/2218-273X/10/5/687
16. Herbert V. Unproven (questionable) dietary and nutritional methods in cancer patients. Cancer [Internet]. 1986 Oct 15;58(8 Suppl):1930–41 [cited 2025 Nov 25]. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/1097-0142(19861015)58:8+
17. NIH Office of Dietary Supplements. Dietary Supplement Label Database – Amvilab brand products [Internet]. 2025 [cited 2025 Nov 25]. Available from: https://dsld.od.nih.gov/brand-products/Amvilab
18. NIH Office of Dietary Supplements. Amevit Kids – label [Internet]. 2025 [cited 2025 Nov 25]. Available from: https://dsld.od.nih.gov/label/298131
19. Ubuy France. Amvilab Magnesium and Vitamin B6 – Promotes Bone Mineralization, Helps Support Nerve and Muscle Function [Internet]. 2024 [cited 2025 Nov 25]. Available from: https://www.ubuy.fr/…/amvilab-magnesium-and-vitamin-b6
20. GoSupps. Amvilab Prostate Expert – Natural Supplement for Prostate Health & Urinary Tract Support [Internet]. 2024 [cited 2025 Nov 25]. Available from: https://www.gosupps.com/brands/amvilab.html
21. Ubuy India. Amvilab Venous Support – Diosmin 450 mg & Hesperidin 50 mg Complex [Internet]. 2024 [cited 2025 Nov 25]. Available from: https://www.ubuy.co.in/…/amvilab-venous-support
22. Parliament of Georgia. Food Products/Animal Feed Safety, Veterinary and Plant Protection Code of Georgia (No. 6155-IS of 2012) [Internet]. 2012 May 8 [cited 2025 Nov 25]. Available from: https://matsne.gov.ge/document/view/1659434 (Georgian)
23. Parliament of Georgia. Law of Georgia on Advertising [Internet]. 1998 Feb 18 (as amended) [cited 2025 Nov 25]. Available from: https://assets.tobaccocontrollaws.org/…/Georgia-Law-on-Advertising.pdf
24. Grata International. Advertising and Promotion of Pharmaceutical Products and Biologically Active Additives in Georgia [Internet]. 2024 Apr 29 [cited 2025 Nov 25]. Available from: https://gratanet.com/publications/advertising-and-promotion-of-pharmaceutical-products-and-biologically-active-additives-in-georgia
25. Media Development Foundation. Surreptitious Advertising [Internet]. Tbilisi (GE); 2011 Oct 12 [cited 2025 Nov 25]. Available from: https://mdfgeorgia.ge/uploads//Surreptitious_Advertising-ENG.pdf
26. Todua N, Mghebrishvili B. Legal fundamentals of food safety provisions in Georgia. Ann Agrar Sci. 2018;16(3):260–6. Available from: https://www.researchgate.net/publication/328149960_Legal_Fundamentals_of_Food_Safety_Provisions_in_Georgia
27. GPC. Amevit kids gummies #30 [Internet]. Tbilisi (GE): GPC; 2025 [cited 2025 Nov 25]. Available from: https://gpc.ge/…/amevit-kids-gummies-30
28. Pharmadepot. Amevit kids gummies #30 [Internet]. Tbilisi (GE): Pharmadepot; 2025 [cited 2025 Nov 25]. Available from: https://pharmadepot.ge/…/amevit-kids-gummies-30
29. Aversi. Amevit kids marmelad #30 [Internet]. Tbilisi (GE): Aversi; 2025 [cited 2025 Nov 25]. Available from: https://shop.aversi.ge/…/amevit-kids-marmelad-30
30. Veli.store. Amvilab Amevit Kids, 30 Piece [Internet]. Tbilisi (GE): Veli.store; 2025 [cited 2025 Nov 25]. Available from: https://veli.store/…/amvilab-amevit-kids-30-piece
31. SheniEkimi.ge. „Amevit Kids“ – Amvilab: რატომ ვერ ვურჩევთ ამ ვიტამინს? [Internet]. Tbilisi (GE): SheniEkimi; 2025 Sep 1 [cited 2025 Nov 25]. Available from: https://sheniekimi.ge/…/amevit-kids-amvilab-რატომ-ვერ-ვურჩევთ-ამ
32. Tabish SA. Complementary and alternative healthcare: is it evidence-based? Indian J Urol. 2008;24(3):221–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3068720/
33. Hathcock JN. Dietary supplements: how they are used and regulated. J Am Coll Nutr. 2001;20(2):98–105. Available from: https://www.sciencedirect.com/science/article/pii/S0022316622148091